10-Q Filing

Niagen Bioscience, Inc. CIK: 1386570 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001628280-22-022216`
Period End Date	20220630
Filing Date	20220810
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	cdcx-20220630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 56 Cash Flow Statement 74 Stockholders Equity 29

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Restricted cash	`RestrictedCash`	$200.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$200.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$200.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$200.00K	USD	Point-in-time
Trade receivables, allowance	`AllowanceForDoubtfulAccountsReceivableCurrent`	$54.00K	USD	Point-in-time
Trade receivables, allowance	`AllowanceForDoubtfulAccountsReceivableCurrent`	$65.00K	USD	Point-in-time
Receivables from Related Party	`AccountsReceivableRelatedPartiesCurrent`	$2.10M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $0.2 million as of both dates	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.07M	USD	Point-in-time
Receivables from Related Party	`AccountsReceivableRelatedPartiesCurrent`	$1.30M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $0.2 million as of both dates	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$38.78M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $0.2 million as of both dates	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.70M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $0.2 million as of both dates	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.22M	USD	Point-in-time
Common stock par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Trade receivables, net of allowances of $54 and $65, respectively; Including receivables from Related Party of: $1.3 million and $2.1 million, respectively	`AccountsReceivableNetCurrent`	$5.23M	USD	Point-in-time
Trade receivables, net of allowances of $54 and $65, respectively; Including receivables from Related Party of: $1.3 million and $2.1 million, respectively	`AccountsReceivableNetCurrent`	$4.23M	USD	Point-in-time
Common stock par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventories	`InventoryNet`	$13.60M	USD	Point-in-time
Inventories	`InventoryNet`	$15.75M	USD	Point-in-time
Common stock authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock issued (in shares)	`CommonStockSharesIssued`	68.16M	shares	Point-in-time
Common stock issued (in shares)	`CommonStockSharesIssued`	68.13M	shares	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssets`	$1.46M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssets`	$1.86M	USD	Point-in-time
Common stock outstanding (in shares)	`CommonStockSharesOutstanding`	68.13M	shares	Point-in-time
Common stock outstanding (in shares)	`CommonStockSharesOutstanding`	68.16M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$48.91M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$38.51M	USD	Point-in-time
Leasehold improvements and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$3.00M	USD	Point-in-time
Leasehold improvements and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$2.90M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$857.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$758.00K	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$4.35M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$3.88M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$564.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$723.00K	USD	Point-in-time
Total assets	`Assets`	$57.84M	USD	Point-in-time
Total assets	`Assets`	$46.61M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.20M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.42M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.70M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.48M	USD	Point-in-time
Current maturities of operating lease obligations	`OperatingLeaseLiabilityCurrent`	$528.00K	USD	Point-in-time
Current maturities of operating lease obligations	`OperatingLeaseLiabilityCurrent`	$646.00K	USD	Point-in-time
Current maturities of finance lease obligations	`FinanceLeaseLiabilityCurrent`	$20.00K	USD	Point-in-time
Current maturities of finance lease obligations	`FinanceLeaseLiabilityCurrent`	$13.00K	USD	Point-in-time
Customer deposits	`DeferredIncomeCurrent`	$173.00K	USD	Point-in-time
Customer deposits	`DeferredIncomeCurrent`	$161.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$17.73M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$17.61M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityNoncurrent`	$4.35M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityNoncurrent`	$4.23M	USD	Point-in-time
Operating lease obligations, less current maturities	`OperatingLeaseLiabilityNoncurrent`	$3.88M	USD	Point-in-time
Operating lease obligations, less current maturities	`OperatingLeaseLiabilityNoncurrent`	$4.15M	USD	Point-in-time
Total liabilities	`Liabilities`	$25.84M	USD	Point-in-time
Total liabilities	`Liabilities`	$26.11M	USD	Point-in-time
Commitments and Contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; authorized 150,000 shares; 68,155 shares and 68,126 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$68.00K	USD	Point-in-time
Common stock, $0.001 par value; authorized 150,000 shares; 68,155 shares and 68,126 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$68.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$203.80M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$200.61M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-168.95M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-183.09M	USD	Point-in-time
Cumulative translation adjustments	`TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax`	$-2.00K	USD	Point-in-time
Cumulative translation adjustments	`TranslationAdjustmentFunctionalToReportingCurrencyNetOfTax`	$2.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$16.42M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$43.83M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$31.73M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$20.78M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$42.14M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$25.88M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$57.84M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$46.61M	USD	Point-in-time

Income Statement 56 line items

Line Item	Tag	Value	Unit	Period
Sales, net	`Revenues`	$16.73M	USD	1 Quarter
Sales, net	`Revenues`	$32.38M	USD	2 Qtrs
Sales, net	`Revenues`	$17.70M	USD	1 Quarter
Sales, net	`Revenues`	$33.99M	USD	2 Qtrs
Cost of sales	`CostOfRevenue`	$6.89M	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$12.34M	USD	2 Qtrs
Cost of sales	`CostOfRevenue`	$6.69M	USD	1 Quarter
Cost of sales	`CostOfRevenue`	$13.42M	USD	2 Qtrs
Gross profit	`GrossProfit`	$10.81M	USD	1 Quarter
Gross profit	`GrossProfit`	$20.57M	USD	2 Qtrs
Gross profit	`GrossProfit`	$10.04M	USD	1 Quarter
Gross profit	`GrossProfit`	$20.04M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$8.02M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$12.49M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$16.26M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$6.23M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.32M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.25M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.79M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.00M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$7.16M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$18.68M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$9.13M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$16.11M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$16.43M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$32.96M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$16.36M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$34.69M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-6.39M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-12.92M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-5.55M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-14.12M	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$12.00K	USD	1 Quarter
Interest expense, net	`InterestExpense`	$10.00K	USD	1 Quarter
Interest expense, net	`InterestExpense`	$31.00K	USD	2 Qtrs
Interest expense, net	`InterestExpense`	$18.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.40M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-14.14M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-12.95M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.57M	USD	1 Quarter
Basic loss per common share (in dollars per share)	`EarningsPerShareBasic`	$-0.20	USD	2 Qtrs
Basic loss per common share (in dollars per share)	`EarningsPerShareBasic`	$-0.08	USD	1 Quarter
Basic loss per common share (in dollars per share)	`EarningsPerShareBasic`	$-0.09	USD	1 Quarter
Basic loss per common share (in dollars per share)	`EarningsPerShareBasic`	$-0.21	USD	2 Qtrs
Diluted loss per common share (in dollars per share)	`EarningsPerShareDiluted`	$-0.21	USD	2 Qtrs
Diluted loss per common share (in dollars per share)	`EarningsPerShareDiluted`	$-0.09	USD	1 Quarter
Diluted loss per common share (in dollars per share)	`EarningsPerShareDiluted`	$-0.20	USD	2 Qtrs
Diluted loss per common share (in dollars per share)	`EarningsPerShareDiluted`	$-0.08	USD	1 Quarter
Basic weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	68.34M	shares	1 Quarter
Basic weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	66.09M	shares	2 Qtrs
Basic weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	68.33M	shares	2 Qtrs
Basic weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	67.99M	shares	1 Quarter
Diluted weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	68.33M	shares	2 Qtrs
Diluted weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	68.34M	shares	1 Quarter
Diluted weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	66.09M	shares	2 Qtrs
Diluted weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	67.99M	shares	1 Quarter

Cash Flow Statement 74 line items

Line Item	Tag	Value	Unit	Period
Restricted cash	`RestrictedCash`	$200.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$200.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$200.00K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$200.00K	USD	Point-in-time
Net loss	`NetIncomeLoss`	$-6.40M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-14.14M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-12.95M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.57M	USD	1 Quarter
Depreciation of leasehold improvements and equipment	`Depreciation`	$447.00K	USD	2 Qtrs
Depreciation of leasehold improvements and equipment	`Depreciation`	$413.00K	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$99.00K	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$121.00K	USD	2 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$254.00K	USD	2 Qtrs
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$468.00K	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$3.18M	USD	2 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$1.30M	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$1.62M	USD	1 Quarter
Share-based compensation expense	`ShareBasedCompensation`	$2.90M	USD	2 Qtrs
Loss on disposal of leasehold improvements and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-5.00K	USD	2 Qtrs
Loss on disposal of leasehold improvements and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	2 Qtrs
Provision for doubtful trade receivables	`ProvisionForDoubtfulAccounts`	$26.00K	USD	2 Qtrs
Provision for doubtful trade receivables	`ProvisionForDoubtfulAccounts`	$22.00K	USD	2 Qtrs
Non-cash financing costs	`OtherNoncashIncomeExpense`	$-57.00K	USD	2 Qtrs
Non-cash financing costs	`OtherNoncashIncomeExpense`	$-34.00K	USD	2 Qtrs
Trade receivables	`IncreaseDecreaseInOtherReceivables`	$-976.00K	USD	2 Qtrs
Trade receivables	`IncreaseDecreaseInOtherReceivables`	$3.33M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$2.15M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$500.00K	USD	2 Qtrs
Implementation costs for cloud computing arrangement	`ImplementationCostsForCloudComputingArrangement`	$204.00K	USD	2 Qtrs
Implementation costs for cloud computing arrangement	`ImplementationCostsForCloudComputingArrangement`	$79.00K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-529.00K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-171.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-226.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$525.00K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-564.00K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$215.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-118.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	-	USD	2 Qtrs
Customer deposits and other	`IncreaseDecreaseInDeferredRevenue`	$-68.00K	USD	2 Qtrs
Customer deposits and other	`IncreaseDecreaseInDeferredRevenue`	$16.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-154.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-312.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.30M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-11.03M	USD	2 Qtrs
Purchases of leasehold improvements and equipment	`PurchasesOfLeaseholdImprovementsAndEquipment`	$110.00K	USD	2 Qtrs
Purchases of leasehold improvements and equipment	`PurchasesOfLeaseholdImprovementsAndEquipment`	$311.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-311.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-110.00K	USD	2 Qtrs
Proceeds from issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$26.74M	USD	2 Qtrs
Proceeds from issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$9.02M	USD	2 Qtrs
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	2 Qtrs
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$47.00K	USD	2 Qtrs
Principal payments on finance leases	`FinanceLeasePrincipalPayments`	$25.00K	USD	2 Qtrs
Principal payments on finance leases	`FinanceLeasePrincipalPayments`	$7.00K	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$35.69M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-7.00K	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$22.08M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-11.15M	USD	2 Qtrs
Cash and cash equivalents, including restricted cash of $0.2 million for both periods - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.07M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $0.2 million for both periods - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$38.78M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $0.2 million for both periods - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.70M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $0.2 million for both periods - beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.22M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $0.2 million for both periods - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.07M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $0.2 million for both periods - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$38.78M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $0.2 million for both periods - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$16.70M	USD	Point-in-time
Cash and cash equivalents, including restricted cash of $0.2 million for both periods - end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$28.22M	USD	Point-in-time
Cash payments for interest on finance leases	`FinanceLeaseInterestPaymentOnLiability`	-	USD	2 Qtrs
Cash payments for interest on finance leases	`FinanceLeaseInterestPaymentOnLiability`	$1.00K	USD	2 Qtrs
Cash payments for principal on operating lease liabilities	`OperatingLeasePayments`	$204.00K	USD	2 Qtrs
Cash payments for principal on operating lease liabilities	`OperatingLeasePayments`	$312.00K	USD	2 Qtrs
Right-of-use assets and operating lease obligations incurred for entering into lease amendment	`RightOfUseAssetsAndOperatingLeaseLiabilitiesIncurredDueToLeaseAmendment`	$2.21M	USD	2 Qtrs
Right-of-use assets and operating lease obligations incurred for entering into lease amendment	`RightOfUseAssetsAndOperatingLeaseLiabilitiesIncurredDueToLeaseAmendment`	-	USD	2 Qtrs

Stockholders Equity 29 line items

Line Item	Tag	Value	Unit	Period
Offering costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$300.00K	USD	1 Quarter
Offering costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$400.00K	USD	2 Qtrs
Beginning balance	`StockholdersEquity`	$16.42M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$43.83M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$31.73M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$20.78M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$42.14M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$25.88M	USD	Point-in-time
Issuance of common stock, net of offering costs	`IssuanceOfCommonStockNetOfOfferingCostsAmount`	$26.74M	USD	2 Qtrs
Issuance of common stock, net of offering costs	`IssuanceOfCommonStockNetOfOfferingCostsAmount`	$1.87M	USD	1 Quarter
Issuance of common stock resulting from the exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$9.02M	USD	2 Qtrs
Issuance of common stock resulting from the exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$391.00K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.18M	USD	2 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.30M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$2.90M	USD	2 Qtrs
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.62M	USD	1 Quarter
Translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$2.00K	USD	1 Quarter
Translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$4.00K	USD	2 Qtrs
Translation adjustment	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$1.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.40M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-14.14M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-12.95M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-5.57M	USD	1 Quarter
Ending balance	`StockholdersEquity`	$16.42M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$43.83M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$31.73M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$20.78M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$42.14M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$25.88M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.